MKEA.F Stock Overview
A medical device company, manufactures and sells medical devices in Europe and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Mauna Kea Technologies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.37 |
| 52 Week High | €0.37 |
| 52 Week Low | €0.37 |
| Beta | 1.36 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -74.48% |
| 5 Year Change | -80.53% |
| Change since IPO | -97.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| MKEA.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.1% | 0.3% |
| 1Y | n/a | 19.4% | 32.4% |
Return vs Industry: Insufficient data to determine how MKEA.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how MKEA.F performed against the US Market.
Price Volatility
| MKEA.F volatility | |
|---|---|
| MKEA.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MKEA.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MKEA.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 68 | Sacha Loiseau | www.maunakeatech.com |
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions.
Mauna Kea Technologies SA Fundamentals Summary
| MKEA.F fundamental statistics | |
|---|---|
| Market cap | US$24.78m |
| Earnings (TTM) | -US$4.00m |
| Revenue (TTM) | US$11.82m |
2.1x
P/S Ratio-6.2x
P/E RatioIs MKEA.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MKEA.F income statement (TTM) | |
|---|---|
| Revenue | €11.03m |
| Cost of Revenue | €2.10m |
| Gross Profit | €8.93m |
| Other Expenses | €12.66m |
| Earnings | -€3.73m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 26, 2024
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 80.98% |
| Net Profit Margin | -33.80% |
| Debt/Equity Ratio | -169.3% |
How did MKEA.F perform over the long term?
See historical performance and comparison